» Articles » PMID: 23983897

Oxidative Stress and the Pathogenesis of Alzheimer's Disease

Overview
Publisher Wiley
Date 2013 Aug 29
PMID 23983897
Citations 335
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly. Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death. A complicated array of molecular events has been implicated in the pathogenesis of AD. The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss. Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD. However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive. The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance. The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity. In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.

Citing Articles

Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E ε4.

Kim S, Keum M, Choe Y, Suh G, Lee B, Kim H Nutrients. 2025; 17(3).

PMID: 39940451 PMC: 11819958. DOI: 10.3390/nu17030595.


Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.

Abdelhamid M, Counts S, Zhou C, Hida H, Kim J, Michikawa M Nutrients. 2025; 17(3).

PMID: 39940416 PMC: 11820889. DOI: 10.3390/nu17030558.


Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.

Mengr A, Smotkova Z, Pacesova A, Zelezna B, Kunes J, Maletinska L J Neuroimmune Pharmacol. 2025; 20(1):18.

PMID: 39932627 PMC: 11813825. DOI: 10.1007/s11481-025-10174-w.


Scopolamine-induced memory impairment in mice: Soursop leaf extract and fractions protect the hippocampus and prefrontal cortex.

Afolabi F, Alabi B, Badejo J, Nsor O, Lawal S, Iwalewa E Iran J Basic Med Sci. 2025; 28(3):355-365.

PMID: 39906616 PMC: 11790190. DOI: 10.22038/ijbms.2024.80289.17379.


Evaluating the antioxidant, anti-inflammatory, and neuroprotective potential of fruiting body and mycelium extracts from edible yellow morel (Morchella esculenta L. Pers.).

Haider R, Agnello L, Shah S, Sufyan M, Khan N, Nazir A J Food Sci. 2025; 90(1):e17619.

PMID: 39865641 PMC: 11771672. DOI: 10.1111/1750-3841.17619.


References
1.
Lynch T, Cherny R, Bush A . Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions. Exp Gerontol. 2000; 35(4):445-51. DOI: 10.1016/s0531-5565(00)00112-1. View

2.
Mecocci P, MacGarvey U, Beal M . Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol. 1994; 36(5):747-51. DOI: 10.1002/ana.410360510. View

3.
Gabbita S, Lovell M, Markesbery W . Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem. 1998; 71(5):2034-40. DOI: 10.1046/j.1471-4159.1998.71052034.x. View

4.
Zhu X, Raina A, Rottkamp C, Aliev G, Perry G, Boux H . Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem. 2001; 76(2):435-41. DOI: 10.1046/j.1471-4159.2001.00046.x. View

5.
Eckert A, Schulz K, Rhein V, Gotz J . Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol. 2010; 41(2-3):107-14. PMC: 2876263. DOI: 10.1007/s12035-010-8109-5. View